Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
T & H Smith
Edinburgh, Scotland, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
T & H Smith was a pioneering Scottish pharmaceutical company founded in 1827, renowned for its expertise in alkaloid extraction and the large-scale production of opiates. The company operated the Blandfield Chemical Works in Edinburgh and became one of the world's leading suppliers of morphine, codeine, and other medicinal chemicals. Throughout the 19th and early 20th centuries, it played a critical role in supplying essential medicines to the medical profession and the military. In 1962, T & H Smith merged with Duncan, Flockhart & Co and Macfarlan Smith to form Edinburgh Pharmaceutical Industries (EPI). This new entity was acquired by Glaxo in 1963, integrating T & H Smith's legacy into the lineage of what is now GSK.
- Therapeutic areas
- PulmonologyNeurologyOther
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on T & H Smith.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on T & H Smith.